Sitagliptin Utilization in Diabetic Patients with Coronary Artery Disease for Improving Cardiovascular Outcomes (SUPERIOR study)

Trial Profile

Sitagliptin Utilization in Diabetic Patients with Coronary Artery Disease for Improving Cardiovascular Outcomes (SUPERIOR study)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Oct 2013

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Cardiovascular disorders; Coronary artery disease; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms SUPERIOR
  • Most Recent Events

    • 02 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top